Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells: specialized antigen presenting cells.

M Di Nicola1, R M Lemoli

  • 1"C. Gandini" Bone Marrow Transplantation Unit, Division of Medical Oncology, Istituto Nazionale Tumori, via Venezian 1, 20133 Milano, Italy. dinicola@istitutotumori.mi.it.

Haematologica
|February 22, 2000
PubMed
Summary

Dendritic cell (DC) based cancer immunotherapy shows promise, building on animal and early clinical trial success. Understanding DC biology is key for developing anti-tumor immunity and insights into allergic, autoimmune diseases, and tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study.

Journal of psychopharmacology (Oxford, England)·2024
Same author

Hematoma at the insertion of the medial rectus mimicking a conjunctival melanoma.

Journal francais d'ophtalmologie·2023
Same author

Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease.

Immunity & ageing : I & A·2023
Same author

Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy.

ESMO open·2021
Same author

Biological insight into the extracellular vesicles in women with and without gestational diabetes.

Journal of endocrinological investigation·2020

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Renewed interest in cancer immunotherapy stems from successful animal models and early clinical trials using dendritic cell (DC) based approaches.
  • Dendritic cells play a crucial role in initiating immune responses, making them a potential tool for stimulating specific anti-tumor immunity.

Framework:

  • The workshop focused on the central role of DCs in immune response initiation.
  • Exploration of DC biology offers insights into mechanisms of allergic and autoimmune diseases.
  • Understanding DC functions is vital for comprehending immune tolerance phenomena.

Implementation:

  • The report is based on a workshop organized by the Italian Society for Experimental Hematology.
  • Key issues were critically reviewed by experts in the field.

Related Experiment Videos

  • The findings were compiled into a report for researchers and clinicians.

    • Implications:

    • DC-based immunotherapy holds significant potential for cancer treatment.
    • Further research into DC biology can lead to advancements in treating autoimmune and allergic diseases.
    • This work contributes to a deeper understanding of immune regulation and tolerance.